Immunovia AB
IMMNOV
Rank in Stocks
#35729
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for... Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Share Price
$0.00982903
Last synced: 2026-10-16
Market Cap
$3.37M
Change (1 day)
-4.35%
Change (1 year)
-71.53%
Country
SE
Trade Immunovia AB (IMMNOV)
Category
Healthcare
Market Capitalization of Immunovia AB(IMMNOV)
Market Cap: $3.37M
As of October 2026 Immunovia AB has a market cap of $3.37M. This makes Immunovia AB the world's 35729th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Immunovia AB from 2018 to 2026
IMMNOV compared with Top 5 Most Popular stocks
